MedPath

MAYFAIR DEVELOPMENTS

🇹🇳Tunisia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Evaluation of the Elimination of Tinnitus and Hyperacusis by the ØREBLUE® Method

Conditions
Tinnitus
Hyperacusis
First Posted Date
2021-02-12
Last Posted Date
2021-02-18
Lead Sponsor
Mayfair Developments
Target Recruit Count
40
Registration Number
NCT04752176
Locations
🇫🇷

Hearing Institute of Resources, La Rochelle, France

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.